SCHEDULE Filed 2025-02-14 Event 2025-02-12 SEC 0001171843-25-000871 →

Nijhawan Pardeep → Edesa Biotech, Inc. EDSA

Stake: 19.99% Shares: 1,596,581 CUSIP: 27966L306 Class: Common Shares, no par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 5.36

282,929 shares short · -0.1% vs prior

Post-Filing Returns · since 2025-02-12 on EDSA

+1 day

+74.7%

+5 days

+34.4%

+30 days

+28.5%

+60 days

+28.0%

+90 days

+7.5%

+180 days

+13.4%

Anchor price 1.86 on closest trading day on/after 2025-02-12. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Edesa Biotech, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-18	SCHEDULE 13G	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →
2026-06-16	SCHEDULE 13D/A	Nijhawan Pardeep	—	1,164,676	view →
2020-01-23	SC	10379085 Canada Inc.	—	—	view →
2020-01-16	SC	Lumira Capital Investment Management Inc.	—	—	view →
2020-01-16	SC	Pardeep Nijhawan Medicine Professional Corp	—	—	view →
2019-09-10	SC	10379085 Canada Inc.	—	—	view →
2019-09-10	SC	Inveready Innvierte Biotech II, S.C.R. S.A	—	—	view →

Other Filings by Nijhawan Pardeep

Filed	Form	Issuer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	EDESA BIOTECH, INC. EDSA	—	1,164,676	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →